Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
6.24 USD | -2.19% | -10.09% | -29.49% |
05-10 | Palisade Bio, Inc. announced that it has received $3.999943 million in funding | CI |
05-07 | Palisade Bio, Inc. Appoints Margery Fischbein to Its Board of Directors | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.49% | 5.43M | |
+33.17% | 49.46B | |
+1.97% | 42.58B | |
+49.11% | 42.49B | |
-4.22% | 29.09B | |
+12.10% | 26.61B | |
-23.12% | 18.64B | |
+8.48% | 13.16B | |
+30.32% | 12.55B | |
+24.17% | 12.1B |
- Stock Market
- Equities
- SNCA Stock
- News Palisade Bio, Inc.
- Palisade Bio Collaborating With Strand Life Sciences on Ulcerative Colitis Therapy